Anti-inflammatory effects of Nelumbo leaf extracts and identification of their metabolites.

BACKGROUND/
OBJECTIVES: Nelumbo leaves have been used in traditional medicine to treat bleeding, gastritis, hemorrhoids, and halitosis. However, their mechanisms have not been elucidated. MATERIALS/
METHODS: The present study prepared two Nelumbo leaf extracts (NLEs) using water or 50% ethanol. Inflammatory response was induced with LPS treatment, and expression of pro-inflammatory mediators (inducible nitric oxide synthase, cyclooxygenase-2, tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 and nitric oxide (NO) and prostaglandin E2 (PGE2) productions were assessed. To determine the anti-inflammatory mechanism of NLEs, we measured nuclear factor-κB (NF-κB) activity. Major metabolites of NLEs were also analyzed and quantified.
RESULTS: NLEs effectively reduced the expression and productions of pro-inflammatory mediators such as IL-1β, IL-6, TNF-α, PGE2, and NO. NLEs also reduced NF-κB activity by inhibiting inhibitor of NF-κB phosphorylation. Both extracts contained catechin and quercetin, bioactive compounds of NLEs.
CONCLUSIONS: In this study, we showed that NLEs could be used to inhibit NF-κB-mediated inflammatory responses. In addition, our data support the idea that NLEs can ameliorate disease conditions involving chronic inflammation.

INTRODUCTION

Inflammation is a natural response that promotes the survival of a host in the presence of a variety of internal and external insults [1]. However, abnormal regulation of inflammatory processes can result in the destruction of cells, or may disturb cellular metabolism and thus contribute to the development of chronic diseases. Macrophages play a central role in the innate immune response and chronic inflammation processes by secreting pro-inflammatory cytokines such as interleukin (IL)-6 and tumor necrosis factor-α (TNF-α) [12]. Macrophages activate inflammation-related genes that are regulated via nuclear factor-κB (NF-κB) signaling [3]. Activated NF-κB translocates to the nucleus, where it induces the expression of pro-inflammatory mediators and cytokines, including inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), TNF-α, IL-1β, and IL-6 [34]. Expression of these proteins elicits further immune responses. Recent studies have identified sustained activation of signaling pathways relevant to inflammation in various pathological conditions, suggesting that this is a crucial underlying cause of many chronic diseases such as atherosclerosis, cardiovascular disease, autoimmune disease, rheumatoid arthritis, cancer, and diabetes [56].

The immunomodulatory effects of plant extracts have been explored to investigate whether these could prevent chronic diseases that are caused by overproduction of pro-inflammatory mediators. The Nelumbo nucifera Gaertn belongs to the Nymphaeaceae family and is an aquatic perennial plant that is widely cultivated throughout Eastern Asia, Australia, and India for food, beverages, ornamental, and therapeutic purposes [7]. All parts of the Nelumbo, including the leaves, fruits, flowers, rhizomes, and seeds, have been reported to have pharmacological effects [89]. Nelumbo leaves have been used as a vegetable and a functional food, as well as to make tea and alcoholic beverages in Korea [910]. The Nelumbo leaf is used in folk medicine to treat bleeding, gastritis, hemorrhoids, mouth inflammation, and halitosis [111213]. The health-promoting effects of Nelumbo in diabetes, cancer, hepatoxicity, and obesity have been associated with its antioxidant activity [1415161718]. This has been attributed to the presence of flavonoids and other phenolic substances. Nelumbo leaves contain quercetin, myricetin, kaempferol, diosmetin, and isorhamnetin derivatives [819]. The catechol structure within flavonoids is a hydrogen atomdonating group that scavenges reactive oxygen species (ROS) and thereby exerts antioxidant effects [20]. For instance, Nelumbo leaf extract (NLE)-derived quercetin was demonstrated to be a potent flavonoid that prevented low-density lipoprotein oxidation [14]. It was also suggested to exert antibacterial activity [12]. However, even though Nelumbo leaf is commonly administered as a tea or alcoholic beverage, its active compounds have generally been analyzed using methanol or ethyl acetate extracts. Since the solvent properties determine which compounds are extracted, the active compounds administered in aqueous extracts may differ from those analyzed in organic solvent extracts.

Metabolomics is an emerging tool for non-targeted profiling and identification of all metabolites in a sample and it is being applied to various comprehensive plant analyses [21]. The resulting data are subjected to multivariate statistical analysis using principal component analysis (PCA), partial least-squares discriminatory analysis (PLS-DA), or orthogonal PLS-DA (OPLS-DA) to identify different groups and screen for effective discriminants. This technique can provide a useful tool for the identification and comparison of plant extract constituents.

In this study, we investigated and compared the anti-inflammatory effects of water- or ethanol-based NLEs. In addition, we determined the possible active compounds present in these extracts.

METHODS AND MATERIALS

Preparation of NLEs

Nelumbo leaves were purchased from Dadobang (Seoul, South Korea). Steamed and dried leaves were extracted with either 50% ethanol or water. These extracts were filtered, rotary evaporated, and lyophilized. The resulting Nelumbo leaf ethanol extract (NLEE) or water extract (NLWE) was dissolved in dimethyl sulfoxide or media and stored at −20℃ until use.

Cell culture

Murine macrophage RAW 264.7 cells were purchased from the Korea Cell Line Bank (Seoul, Korea). Cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% inactivated fetal bovine serum (v/v), 5% penicillin (100 U/ml), and streptomycin (100 µg/ml; Invitrogen, Carlsbad, CA, USA) and maintained at 37℃ in a humidified atmosphere of 5% CO2. Either NLEE or NLWE (1, 10, or 50 µg/ml) was incubated with the plated cells for 24 h prior to the addition of 1 µg/ml of lipopolysaccharide (LPS; Sigma-Aldrich, St. Louis, MO, USA) for the indicated time-period.

Cell viability assay

Cells were pre-incubated with the indicated concentrations of either NLEE or NLWE for 24 h and then stimulated with 1 µg/ml LPS for 18 h. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma-Aldrich, St. Louis, MO, USA). Briefly, cells were incubated with MTT solution for 2 h at 37℃ prior to removing the medium and lysing the cells using isopropanol. The absorbance of the colored solution at 450 nm was quantified by a Spectra MAX 340 microplate reader (Molecular Devices, Sunnyvale, CA, USA).

Measurement of nitric oxide (NO) and prostaglandin E2 (PGE2) productions

RAW 264.7 cells were pre-treated with either NLEE or NLWE (1, 10, or 50 µg/ml) for 24 h and then induced with LPS (1 µg/ml) for 18 h. The supernatants was collected and the levels of nitrite and PGE2 were determined by a nitrate/nitrite Colorimetric Assay kit and a PGE2 enzyme immunoassay kit (Cayman Chemical, Ann Arbor, MI, USA), in accordance with the manufacturer's protocol.

Measurement of pro-inflammatory cytokine production

Cells were pre-treated with either NLEE or NLWE and then stimulated with LPS for 18 h prior to collecting the cell cultures media and analyzing the levels of TNF-α, IL-1β, and IL-6 using enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN, USA).

RNA preparation and reverse transcriptase-polymerase chain reaction (RT-PCR)

RAW 264.7 cells were incubated with either NLEE or NLWE for 24 h and then induced by LPS (1 µg/ml) for 4 h. Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to manufacturer's instructions and stored at -80℃ until use. Total RNA was reverse-transcribed using a Superscript First Strand Synthesis System (Invitrogen, Carlsbad, CA, USA). All PCR analyses were subsequently carried out using a GenePro Thermal Cycler (Bioer Technology Co. Ltd., Hangzhou, China). After an initial denaturation at 95℃ for 5 min, 25-30 amplification cycles were conducted in the following order: denaturation at 95℃ for 30 sec, annealing at varying temperatures for 30 sec, and elongation at 72℃ for 1 min. A final extension step was carried out at 72℃ for 10 min. After amplification, PCR products were separated by electrophoresis on a 1% agarose gel and visualized under UV light.

Western blot analysis

After NLEE or NLWE pre-treatment, cells were stimulated with LPS for either 15 min or 18 h and then lysed in RIPA lysis buffer containing cocktail protease inhibitors and phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO, USA). Cell debris was removed by centrifugation for 30 min at 10,000 g at 4℃. Protein concentrations were determined using a Bradford Assay kit (Bio-Rad, Hercules, CA, USA), according to the manufacturer's instructions. Lysates were boiled in sample buffer for 5 min. Equivalent amounts of sample protein were then separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Membranes were blocked with 5% skimmed milk in Tris-buffered saline containing 0.05% Tween-20 for 1 h at room temperature, and then probed with antibodies against iNOS, COX-2, phosphorylated inhibitor of NF-κB (Iκ-B)-α, and β-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The membranes were washed and then exposed to horseradish peroxidase-conjugated secondary antibodies (1:4000 dilutions). Immunoreactive bands were detected by enhanced chemiluminescence solution (Animal Genetics, Seoul, South Korea) and exposed to X-ray film.

Nuclear extraction and NF-κB transcriptional activity assay

Cells were harvested after a 24-h pre-treatment with NLEE or NLWE and 20-min LPS stimulation. Nuclear proteins were extracted using a Nuclear Extraction kit (Cayman, Ann Arbor, MI, USA), and NF-κB transcriptional activity was measured using an NF-κB Transcription Factor Assay kit, according to manufacturer's instructions (Cayman, Ann Arbor, MI, USA).

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis

NLEs were analyzed using a high-performance liquid chromatography (HLPC) system with a PDA Detector (Accela 80 Hz) and an LTQ-Velos ion trap mass spectrometer fitted with a heat electrospray ionization interface (Thermo Fisher Scientific, Waltham, MA, USA) with a C18 column (1.9 µm, 2.0 × 100 mm, UPLC BEH C18, Waters, USA). The elution gradient was carried out with a binary solvent system consisting of 0.1% formic acid in water (solvent A) and 0.1% formic acid in acetonitrile (solvent B) at a constant flow rate of 0.3 ml/min. The linear gradient profile was as follows: 5-10% solvent B over 5 min, 10% solvent B for 10 min, 10-40% solvent B over 30 min, 40-90% solvent B over 40 min, then returned to 5% solvent B over 5 min, followed by conditioning for 10 min, finished at 55 min. Acquisition was performed in the negative and positive ion modes using electrospray ionization. The capillary temperature was 275℃, with sheath gas at 35 units and auxiliary gas at 5 units. NLEs were run in triplicate and the collected data was processed for profiling and identification.

Data processing and analysis for metabolite identification

Peak detection, alignment, and identification were performed using the SIEVE software (Thermo Fisher Scientific, Waltham, MA, USA). The acquired results were analyzed by multivariate statistical analysis using SIMCA (Umetrics, Umea, Sweden). PCA was used to visualize the similarities and differences between NLEE and NLWE, and OPLS-DA was applied to detect maximal separation of distinctive metabolites in each partially purified fraction. The MS/MS fragmentation patterns, retention time, and UV-visible spectra were used for informative non-targeted metabolic profiling and the acquired LC-MS/MS spectrum was compared with those in the MassBank database (www.massbank.jp), KEGG database (www.kegg.jp), Metlin (http://masspec.scripps.edu), and other published reports.

HPLC analysis for quantification of metabolites

Quantification of key metabolites was conducted using a standard curve generated from authentic standards of quercetin and catechin. Analysis was performed by HPLC (Dionex HPLC-3000, Dionex Corp., Sunnyvale, CA, USA) with UV detector (Ultimate 3000 Diode array detector, Dionex Corp., Sunnyvale, CA, USA) using X-bridge C18 column (3.5 um, 4.6 × 150 mm. Waters) at 35℃. The solvents were 0.1% formic acid in water (phase A) and acetonitrile (phase B) at flow rate of 1 mL/ml. The linear gradient profile was as follows: 5-10% B in 5 min, held at 10% B in 5-10 min, 10-40% B in 10-30 min, finished at 30 min. UV spectrum were measured at 275 nm.

Statistical analysis

All data presented were expressed as the mean ± standard error (SE) of three or more independent experiments. Statistical comparisons were made using analysis of variance (ANOVA), followed by Duncan's multiple range test. In all cases, results were considered significant if the P-value was less than 0.05. All statistical tests were performed using SPSS statistical analysis software (Chicago, IL, USA).

RESULTS

Non-cytotoxic levels of NLEs

RAW 264.7 cells were treated with various concentrations of NLEE or NLWE for 24 h prior to examining their viability using MTT assays. There were no significant changes in cell viability (Fig. 1), indicating that neither NLEE nor NLWE was cytotoxic at concentrations of up to 50 µg/ml.

Fig. 1

Effects of NLEs on the viability of RAW 264.7 cells, determined by MTT assay.

The cells were treated with NLEs for 24 h and then stimulated with LPS for 24 h. The values are expressed as the means ± SE of three individual experiments. LPS, lipopolysaccharide; NLEE, Nelumbo leaf ethanol extract; NLWE, Nelumbo leaf water extract.

Effects of NLEs on LPS-induced NO production and iNOS expression

We investigated whether NLEs could modulate NO production in activated RAW 264.7 cells. The cells were pre-treated with NLEE or NLWE (1, 10, or 50 µg/ml) and stimulated with 1 µg/ml of LPS for 18 h prior to determination of the levels of nitrite and iNOS expression. LPS stimulation significantly increased nitrite production by about 3-fold, as compared to unstimulated control cells (Fig. 2A). However, 50 µg/ml of NLEE (IC50 of 201.4 µg/ml) and NLWE (IC50 of 231.2 µg/ml) significantly suppressed LPS-stimulated nitrite production, and iNOS mRNA and protein expressions (Fig. 2B and C). NLWE, at a concentration of greater than 10 µg/ml, significantly reduced iNOS mRNA levels in a concentration-dependent manner (Fig. 2B). In addition, NLEE and NLWE significantly suppressed iNOS protein expression, as compared to the LPS-stimulated control cells. These results indicated that NLEE and NLWE reduced nitrite production and iNOS expression in a concentration-dependent manner.

Fig. 2

Effects of NLEs on NO levels, and iNOS expression in LPS-induced RAW 264.7 cells.

The cells were pre-treated with various concentrations of NLE for 24 h, and then stimulated with LPS (1 µg/ml). (A) NO levels in cell culture media after 16-h incubation with LPS. (B) iNOS mRNA expression, determined by semi-quantitative RT-PCR after 4 h incubation with LPS. (C) iNOS protein expression in cell lysates, determined by western blot analysis. The values are expressed as the mean ± SD of three individual experiments. Values not sharing the same superscript were significantly (P < 0.05) different. LPS, lipopolysaccharide; NLEE, Nelumbo leaf ethanol extract; NLWE, Nelumbo leaf water extract; NO, nitric oxide; iNOS, inducible nitric oxide synthase.

Effects of NLEs on LPS-induced PGE2 production and COX-2 expression

To test the effects of NLEs on pro-inflammatory mediators, PGE2 and COX-2 levels were assessed in RAW 264.7 cells incubated with NLEE or NLWE for 24 h prior to LPS stimulation for either 4 h or 16 h. NLEE (IC50 of 5.3 µg/ml) significantly reduced PGE2 production at a concentration of greater than 1 µg/ml (Fig. 3A). NLWE (IC50 of 4.8 µg/ml) also significantly decreased LPS-induced PGE2 production in a concentration-dependent manner (Fig. 3A). The lowest concentration of NLWE that reduced PGE2 production was 10 µg/ml. Furthermore, NLEE reduced COX-2 mRNA and protein expression. However, NLWE significantly reduced COX-2 protein levels but not its mRNA expression. These results suggested that NLEE reduced the production of the pro-inflammatory mediator, PGE2, and the expression of COX-2 more effectively than NLWE.

Fig. 3

Effects of NLEs on PGE2 levels and COX-2 expression in LPS-induced RAW 264.7 cells.

Cells were pre-treated with NLE for 24 h and then stimulated with LPS (1 µg/ml). (A) PGE2 levels were measured in the culture medium after 16 h incubation with LPS. (B) COX-2 mRNA expression was measured by semi-quantitative RT-PCR after 4 h incubation with LPS. (C) COX-2 protein levels in cell lysates were measured by western blot analysis after 16-h LPS stimulation. The values are expressed as the mean ± SE of three individual experiments. Values not sharing the same superscript were significantly (P < 0.05) different. LPS, lipopolysaccharide; NLEE, Nelumbo leaf ethanol extract; NLWE, Nelumbo leaf water extract; PGE2, prostaglandin E2; COX-2, cyclooxygenase 2.

Effects of NLEs on LPS-induced IL-1β, IL-6, and TNF-α productions and expressions

We investigated whether NLEs influenced the production of the pro-inflammatory cytokines, IL-1β, IL-6, and TNF-α, as well as their gene expression. NLEE (10 µg/ml) was sufficient to suppress IL-1β levels in RAW 264.7 macrophage cells. IL-1β levels were reduced by about 60% in cells exposed to 50 µg/ml NLEE (IC50 of 38.8 µg/ml), as compared to only 25% reduction in those exposed to 50 µg/ml NLWE (IC50 of 88.8 µg/ml) (Fig. 4A). However, both NLEE and NLWE slightly reduced IL-1β mRNA levels. NLWE, but not NLEE, treatment significantly reduced the levels of IL-6, and its mRNA, as compared to LPS-stimulated control cells (Fig. 4B). Both NLEE and NLWE noticeably inhibited the expression and production of TNF-α (Fig. 4C). NLEE (10 µg/ml) significantly decreased TNF-α mRNA and the secreted forms of TNF-α in a concentration-dependent manner. In addition, 1 µg/ml NLWE (IC50 of 38.1 µg/ml) was enough to reduce the secretion of TNF-α (Fig. 4C). Taken together, these NLEs markedly reduced the LPS-stimulated mRNA expression of TNF-α, IL-1β, and IL-6 genes, as well as these cytokine levels, in a concentration-dependent manner.

Fig. 4

Effects of NLEs on cytokine expression.

RAW 264.7 cells were pre-treated with NLEs for 24 h and then stimulated with LPS (1 µg/ml) for 4 or 16 h. Total RNA and protein lysates were subjected to semi-quantitative RT-PCR and western blot analysis to analyze IL-1β (A), IL-6 (B), and TNF-α (C). The values are expressed as the mean ± SD of three individual experiments. Values not sharing the same superscript were significantly (P < 0.05) different. LPS, lipopolysaccharide; NLEE, Nelumbo leaf ethanol extract; NLWE, Nelumbo leaf water extract; IL, interleukin; TNF-α, tumor necrosis factor alpha; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

Effects of NLEs on LPS-induced NF-κB activity and IκB phosphorylation

Since the NF-κB pathway regulates the expression of inflammatory mediators and pro-inflammatory cytokines, we next investigated whether NLEs modulated NF-κB activity. As shown in Fig. 5A, NLEs reduced NF-κB activity in a concentration-dependent manner. NLEE and NLWE significantly reduced NF-κB activity at concentration greater than 10 and 1 µg/ml, respectively. Furthermore, the level of phosphorylated cytosolic IκB was lower in cells pre-treated with NLE for 24 h (Fig. 5B). NLEE and NLWE reduced phosphorylation of IκB at concentrations greater than 50 and 10 µg/ml, respectively. These results indicated that NLE decreased the transcriptional activity of NF-κB by reducing phosphorylation of IκB proteins, and that NLWE produced a more effective reduction in NF-κB activity than NLEE.

Fig. 5

Effects of NLE on NF-µB signaling.

(A) NF-µB transcriptional activity was determined in nuclear extracts of RAW 264.7 cells that were pre-treated with NLEs for 24 h prior to stimulation with LPS (1 µg/ml) for 20 min. (B) IµB phosphorylation was determined in cell lysate proteins from RAW 264.7 cells that were pre-treated with NLEs for 24 h and then induced with LPS (1 µg/ml) for 15 min. The values are expressed as the mean ± SD of three individual experiments. Values not sharing the same superscript were significantly (P < 0.05) different. LPS, lipopolysaccharide; NLEE, Nelumbo leaf ethanol extract; NLWE, Nelumbo leaf water extract; NF-κB, nuclear factor kappa-light-chainenhancer of activated B cells; I-κB, inhibitor of NF-κB.

Identification of the active compounds responsible for anti-inflammatory activity of NLEs

Since NLEs reduced pro-inflammatory mediator and cytokine productions, we determined the major bioactive compounds in NLEs. Multivariate statistical analysis was used to distinguish the metabolites present in NLWE and NLEE. Unsupervised PCA showed a clear differentiation of the metabolites extracted using water and ethanol, as indicated in Fig. 6. The replicates of each extract clustered closely together and were clearly separated into different groups in both of ion detection modes (positive and negative). In negative ion mode, the NLEE metabolites were mainly discriminated from those in the NLWE by component 1 (88.3%), followed by component 2 (10.2%); a higher dependency on component 1 (91.5%) was observed in positive ion mode. Furthermore, the OPLS-DA was used to screen the highly significant metabolites in each extract (Fig. 7). Among 396 metabolites detected by LC-MS/MS analysis in negative ion mode, 57 distinctive metabolites were identified in the NLWE, while 136 were found in the NLEE (P < 0.01). In positive ion mode, these values were 23 in the NLWE and 97 in the NLEE (P < 0.01) (supplementary data). The main compounds identified in each extract are listed and summarized on Table 1. Catechin, rutin, procyanidin B, and quercetin pentosyl hexoside were found in both extracts; these could contribute to the observed anti-inflammatory activities. Since both extracts reduced inflammatory responses, we investigated bioactive compounds which existed in both water and ethanol extracts. The bioactive compounds in both NLE were catechin and quercetin. NLWE and NLEE contained 22.3 and 34.3 µg/mg of catechin and 3.72 and 1.80 µg/mg of quercetin (Fig. 8). Different levels of catechin and quercetin in both extracts could cause anti-inflammatory responses in Raw 264.7 cells.

Fig. 6

PCA of the metabolites in NLWE (black circle) and NLEE (Red pentagon), analyzed by LC-MS/MS in (A) negative ion mode and (B) positive ion mode.

NLEE, Nelumbo leaf ethanol extract; NLWE, Nelumbo leaf water extract.

Fig. 7

S-plot generated by OPLS-DA for the metabolites in NLWE and NLEE, analyzed by LC-ESI-ion trap-MS/MS.

(A) negative ion mode; (B) positive ion mode NLEE, Nelumbo leaf ethanol extract; NLWE, Nelumbo leaf water extract.

Table 1

Metabolites identified in water and ethanol extracts of Nelumbo nucifera leaves, discriminated by orthogonal partial least squared discriminant analysis

Fig. 8

Quantitative analysis of quercetin (A and B) and catechin (C and D) in NLWE and NLEE using HPLC.

Quercetin hydrate standard (A) and quercetin peak from NLEE and NLWE (B). Catechin hydrate standard (C) and catechin peak from NLEE and NLWE (D). NLEE, Nelumbo leaf ethanol extract; NLWE, Nelumbo leaf water extract.

DISCUSSION

In this study, we provide evidence that Nelumbo leaf reduced pro-inflammatory mediators and cytokines expression through suppression of NF-κB activity so Nelumbo leaf can be used as an anti-inflammatory agent or functional food to modulate inflammation.

Since NLEs have shown several health benefits, researchers elucidated their major constituents and identified high levels of phenolic compounds such as catechin, quercetin, and proanthocyanidins [2223]. A range of amounts and types of total phenolic compounds were identified, depending on the extraction solvent employed [24]. Since Nelumbo leaf has been used as a tea or alcoholic beverage in Korea, water and 50% ethanol were used as the extraction solvents in the present study and two major constituents, catechin and quercetin, were found. In this study, we showed that NLEE contained more catechin compared to NLWE (34.3 µg/mg vs. 22.3 µg/mg). Since solubility of catechin has been increased by temperature and ethanol concentration [25], NLEE contained more catechin compared to NLWE. Catechin has been shown to have antitumorigenic and anti-atherosclerotic effects [262728] and these health benefits reflect anti-inflammatory effects [293031]. Catechin reduced gastric inflammation by suppressing IL-8 production in gastric cancer and human umbilical vein endothelial cells [29] and decreased COX-2, iNOS, IL-1β, and TNF-α expression by suppressing NF-κB in skin carcinoma cells [31].

One of major constituents in NLEs was quercetin and NLWE contained more than twice of quercetin compared to NLEE. Quercetin also has been shown to have anti-tumor, antioxidant, and anti-inflammatory properties [323334]. Other study showed that quercetin reduced iNOS and COX-2 expression via inhibition of NF-κB signaling pathways [33]. These findings indicate that two major NLE components, catechin and quercetin, could attenuate LPS-induced inflammatory responses.

Although NLWE and NLEE had strong anti-inflammatory effects, NLWE and NLEE showed different effects on pro-inflammatory mediator and cytokines production and expression. NLWE reduced more of iNOS, IL-6, and TNF-α production and NF-κB activity compared to NLEE and NLEE suppressed PGE2 and IL-1β production. These difference could be caused by metabolites NLEs contained. NLWE contains taxifolin, which suppresses inflammatory responses [353637]. Extracts of Ulmus macrocarparoot or Pinus brutia bark, which mainly contained catechin and taxifolin, inhibited NO production by suppressing iNOS and COX-2 expression [3637]. Moreover, taxifolin glycoside significantly reduced atopic dermatitis by effects on iNOS and COX-2 [35] and also ameliorated cerebral ischemia-reperfusion injury by inhibiting NF-κB activity [38]. However, NLEE contains luteolin which suppressed inflammation in several model through JAK/STAT and/or NF-κB pathway [394041]. Luteolin reduced iNOS expression through inhibition of NF-κB translocation in LPSstimulated RAW 264.7 cells [39]. In addition, luteolin inhibited IL-8 production, and COX-2 and iNOS expression by decrease of JAK/STAT pathway [41]. Therefore, different effects of NLEs on pro-inflammatory mediator or cytokine production and/or expression were caused by metabolites they contained.

The present study provided evidence that NLEs reduced LPS-activated macrophage responses via inhibition of NF-κB activation and two major constituents of these extracts were catechin and quercetin. Moreover, the concentration of NLEs required to exert these anti-inflammatory effects did not cause cytotoxicity. Further in vivo studies are warranted to confirm the anti-inflammatory effects of NLEs in people who are susceptible to inflammation-related diseases. This study indicated that NLEs could be used in a therapeutic approach to the prevention or inhibition of diseases characterized by chronic inflammation related to NF-κB activity.